Organon & Co. (OGN) Financials

$11.06 -0.24 (-2.08%)

Closing price 03:59 PM Eastern

Extended Trading

$11.06 0.00 (0.00%)

As of 07:47 PM Eastern

Annual Income Statements for Organon & Co.

This table shows Organon & Co.'s income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	3,218	2,160	1,351	917	1,023	864
Consolidated Net Income / (Loss)	3,218	2,160	1,351	917	1,023	864
Net Income / (Loss) Continuing Operations	3,306	2,256	1,351	917	1,023	864
Total Pre-Tax Income	3,696	2,752	1,529	1,122	673	807
Total Operating Income	3,762	2,787	1,791	1,570	1,257	1,374
Total Gross Profit	5,503	4,413	3,905	3,880	3,748	3,715
Total Revenue	7,777	6,532	6,304	6,174	6,263	6,403
Operating Revenue	7,777	6,532	6,304	6,174	6,263	6,403
Total Cost of Revenue	2,274	2,119	2,399	2,294	2,515	2,688
Operating Cost of Revenue	2,274	2,119	2,399	2,294	2,515	2,688
Total Operating Expenses	1,741	1,626	2,114	2,310	2,491	2,341
Selling, General & Admin Expense	1,443	1,356	1,668	1,704	1,893	1,760
Research & Development Expense	220	210	443	578	536	550
Restructuring Charge	78	60	3.00	28	62	31
Total Other Income / (Expense), net	-66	-35	-262	-448	-584	-567
Interest Expense	-	0.00	258	437	542	541
Other Income / (Expense), net	-66	-35	-4.00	-11	-42	-26
Income Tax Expense	390	496	178	205	-350	-57
Basic Earnings per Share	$12.69	$8.52	$5.33	$3.61	$4.01	$3.36
Weighted Average Basic Shares Outstanding	253.52M	253.52M	253.54M	254.08M	255.24M	257.05M
Diluted Earnings per Share	$12.69	$8.52	$5.31	$3.59	$3.99	$3.33
Weighted Average Diluted Shares Outstanding	253.52M	253.52M	254.19M	255.17M	256.27M	259.15M
Weighted Average Basic & Diluted Shares Outstanding	-	-	253.64M	254.38M	255.64M	257.95M
Cash Dividends to Common per Share	-	-	$0.56	$1.12	$1.12	$1.12

This table shows Organon & Co.'s income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	227	108	177	242	58	546	201	195	359	109
Consolidated Net Income / (Loss)	227	108	177	242	58	546	201	195	359	109
Net Income / (Loss) Continuing Operations	227	108	177	242	58	546	201	195	359	109
Total Pre-Tax Income	282	111	235	254	80	104	236	235	207	129
Total Operating Income	398	266	382	389	232	254	376	371	339	288
Total Gross Profit	986	895	958	968	907	915	957	939	923	896
Total Revenue	1,537	1,485	1,538	1,608	1,519	1,598	1,622	1,607	1,582	1,592
Total Cost of Revenue	551	590	580	640	612	683	665	668	659	696
Operating Cost of Revenue	551	590	580	640	612	683	665	668	659	696
Total Operating Expenses	588	629	576	579	675	661	581	568	584	608
Selling, General & Admin Expense	440	470	435	451	538	469	431	437	422	470
Research & Development Expense	137	142	137	128	137	134	127	131	162	130
Restructuring Charge	11	17	4.00	0.00	0.00	58	23	0.00	0.00	8.00
Total Other Income / (Expense), net	-116	-155	-147	-135	-152	-150	-140	-136	-132	-159
Interest Expense	108	134	132	133	134	143	131	131	126	153
Other Income / (Expense), net	-8.00	-21	-15	-2.00	-18	-7.00	-9.00	-5.00	-6.00	-6.00
Income Tax Expense	55	3.00	58	12	22	-442	35	40	-152	20
Basic Earnings per Share	$0.89	$0.43	$0.70	$0.95	$0.23	$2.13	$0.78	$0.76	$1.39	$0.43
Weighted Average Basic Shares Outstanding	254.35M	254.08M	254.39M	255.34M	255.59M	255.24M	255.70M	257.29M	257.50M	257.05M
Diluted Earnings per Share	$0.89	$0.42	$0.69	$0.95	$0.23	$2.12	$0.78	$0.75	$1.38	$0.42
Weighted Average Diluted Shares Outstanding	255.07M	255.17M	256.17M	255.95M	256.35M	256.27M	258.36M	258.60M	259.76M	259.15M
Weighted Average Basic & Diluted Shares Outstanding	254.36M	254.38M	255.06M	255.57M	255.61M	255.64M	257.17M	257.47M	257.54M	257.95M

This table details how cash moves in and out of Organon & Co.'s business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	75	-246	667	-31	-13	-18
Net Cash From Operating Activities	3,020	2,284	2,160	858	799	939
Net Cash From Continuing Operating Activities	3,020	2,284	2,160	858	799	939
Net Income / (Loss) Continuing Operations	3,306	2,256	1,351	917	1,023	864
Consolidated Net Income / (Loss)	-	-	1,351	917	1,023	864
Depreciation Expense	49	56	92	96	120	132
Amortization Expense	284	86	103	116	116	145
Non-Cash Adjustments To Reconcile Net Income	41	35	200	199	180	225
Changes in Operating Assets and Liabilities, net	-660	-149	414	-470	-640	-427
Net Cash From Investing Activities	-88	-250	-481	-420	-260	-513
Net Cash From Continuing Investing Activities	-88	-250	-481	-420	-260	-513
Purchase of Property, Plant & Equipment	-92	-255	-192	-196	-251	-175
Acquisitions	0.00	0.00	-296	-231	-10	-342
Sale of Property, Plant & Equipment	4.00	5.00	7.00	7.00	1.00	4.00
Net Cash From Financing Activities	-2,932	-2,022	-977	-433	-569	-368
Net Cash From Continuing Financing Activities	-2,932	-2,022	-977	-433	-569	-368
Repayment of Debt	0.00	0.00	-1,742	-108	-338	-1,235
Payment of Dividends	0.00	0.00	-145	-290	-294	-297
Issuance of Debt	0.00	1,512	9,470	0.00	80	1,186
Other Financing Activities, net	-2,932	-3,534	-8,560	-35	-17	-22
Effect of Exchange Rate Changes	31	-	23	-36	17	-76

This table details how cash moves in and out of Organon & Co.'s business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-46	207	-247	-133	88	279	-118	129	59	-88
Net Cash From Operating Activities	317	267	114	27	261	397	76	332	141	390
Net Cash From Continuing Operating Activities	317	267	114	27	261	397	76	332	141	390
Net Income / (Loss) Continuing Operations	227	108	177	242	58	546	201	195	359	109
Consolidated Net Income / (Loss)	227	108	177	242	58	546	201	195	359	109
Depreciation Expense	25	24	28	28	32	32	32	32	34	34
Amortization Expense	32	28	29	30	29	28	33	34	35	43
Non-Cash Adjustments To Reconcile Net Income	17	52	40	41	44	55	28	50	76	71
Changes in Operating Assets and Liabilities, net	16	55	-160	-314	98	-264	-218	21	-363	133
Net Cash From Investing Activities	-213	-61	-54	-70	-55	-81	-96	-46	-75	-296
Net Cash From Continuing Investing Activities	-213	-61	-54	-70	-55	-81	-96	-46	-75	-296
Purchase of Property, Plant & Equipment	-55	-63	-46	-71	-55	-79	-46	-32	-42	-55
Acquisitions	-160	-2.00	-8.00	-	-	-2.00	-50	-15	-34	-243
Sale of Property, Plant & Equipment	2.00	4.00	-	-	-	-	-	-	1.00	2.00
Net Cash From Financing Activities	-77	-82	-326	-88	-78	-77	-74	-134	-78	-82
Net Cash From Continuing Financing Activities	-77	-82	-326	-88	-78	-77	-74	-134	-78	-82
Repayment of Debt	-	-2.00	-252	-82	-2.00	-2.00	-2.00	-1,077	-2.00	-154
Payment of Dividends	-74	-73	-73	-74	-74	-73	-70	-79	-74	-74
Issuance of Debt	-	-	-	-	-	-	-	-	-	150
Other Financing Activities, net	-3.00	-7.00	-1.00	-12	-2.00	-2.00	-2.00	-14	-2.00	-4.00
Effect of Exchange Rate Changes	-73	83	19	-2.00	-40	40	-24	-23	71	-100

This table presents Organon & Co.'s assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2020	2021	2022	2023	2024
Total Assets	10,109	10,681	10,955	12,058	13,101
Total Current Assets	3,567	3,760	3,931	4,508	4,348
Cash & Equivalents	12	737	706	693	675
Accounts Receivable	1,038	1,382	1,475	1,744	1,358
Inventories, net	913	915	1,003	1,315	1,321
Other Current Assets	930	726	747	756	994
Plant, Property, & Equipment, net	984	973	1,018	1,183	1,168
Total Noncurrent Assets	5,558	5,948	6,006	6,367	7,585
Goodwill	4,603	4,603	4,603	4,603	4,680
Intangible Assets	503	651	649	533	1,414
Other Noncurrent Operating Assets	361	-	754	1,231	1,491
Total Liabilities & Shareholders' Equity	10,109	10,681	10,955	12,058	13,101
Total Liabilities	4,623	12,189	11,847	12,128	12,629
Total Current Liabilities	2,673	2,597	2,512	2,918	2,718
Short-Term Debt	0.00	9.00	8.00	9.00	20
Accounts Payable	1,598	1,382	1,132	1,314	1,153
Accrued Expenses	659	1,021	1,188	1,389	1,411
Current Deferred & Payable Income Tax Liabilities	288	185	184	206	134
Total Noncurrent Liabilities	1,950	9,592	9,335	9,210	9,911
Long-Term Debt	0.00	9,125	8,905	8,751	8,860
Noncurrent Deferred & Payable Income Tax Liabilities	128	4.00	19	47	74
Other Noncurrent Operating Liabilities	1,739	463	411	412	977
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	5,486	-1,508	-892	-70	472
Total Preferred & Common Equity	5,486	-1,508	-892	-70	472
Total Common Equity	5,486	-1,508	-892	-70	472
Common Stock	0.00	3.00	3.00	28	111
Retained Earnings	0.00	-998	-331	443	1,010
Accumulated Other Comprehensive Income / (Loss)	-622	-513	-564	-541	-649

This table presents Organon & Co.'s assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	10,437	10,763	10,979	11,012	11,891	12,154	12,752
Total Current Assets	3,592	3,780	3,958	4,050	4,196	4,509	4,756
Cash & Equivalents	499	459	326	414	575	704	763
Accounts Receivable	1,440	1,445	1,672	1,648	1,547	1,617	1,685
Inventories, net	879	1,121	1,199	1,186	1,263	1,287	1,383
Other Current Assets	774	755	761	802	811	901	925
Plant, Property, & Equipment, net	906	1,055	1,110	1,096	1,180	1,162	1,204
Total Noncurrent Assets	5,939	5,928	5,911	5,866	6,515	6,483	6,792
Goodwill	4,603	4,603	4,603	4,603	4,603	4,603	4,603
Intangible Assets	670	621	592	561	718	684	763
Noncurrent Deferred & Refundable Income Taxes	-	704	716	702	1,194	1,196	1,426
Total Liabilities & Shareholders' Equity	10,437	10,763	10,979	11,012	11,891	12,154	12,752
Total Liabilities	11,503	11,500	11,534	11,601	11,843	12,010	12,259
Total Current Liabilities	2,328	2,346	2,387	2,491	2,545	2,755	2,790
Short-Term Debt	8.00	8.00	8.00	8.00	9.00	9.00	10
Accounts Payable	1,028	996	1,115	1,067	955	1,243	1,092
Accrued Expenses	1,075	1,150	1,101	1,255	1,385	1,302	1,458
Current Deferred & Payable Income Tax Liabilities	217	192	163	161	196	201	230
Total Noncurrent Liabilities	9,175	9,154	9,147	9,110	9,298	9,255	9,469
Long-Term Debt	8,691	8,703	8,722	8,646	8,705	8,647	8,739
Noncurrent Deferred & Payable Income Tax Liabilities	43	30	32	43	44	60	56
Other Noncurrent Operating Liabilities	441	421	393	421	549	548	674
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	-1,066	-737	-555	-589	48	144	493
Total Preferred & Common Equity	-1,066	-737	-555	-589	48	144	493
Total Common Equity	-1,066	-737	-555	-589	48	144	493
Common Stock	3.00	3.00	3.00	3.00	52	66	89
Retained Earnings	-383	-206	-25	-16	573	690	975
Accumulated Other Comprehensive Income / (Loss)	-686	-534	-533	-576	-577	-612	-571

This table displays calculated financial ratios and metrics derived from Organon & Co.'s official financial filings.

Metric	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	-16.01%	-3.49%	-2.06%	1.44%	2.24%
EBITDA Growth	0.00%	-28.17%	-31.51%	-10.65%	-18.07%	11.99%
EBIT Growth	0.00%	-25.54%	-35.07%	-12.76%	-22.07%	10.95%
NOPAT Growth	0.00%	-32.11%	-30.73%	-18.92%	48.91%	-23.01%
Net Income Growth	0.00%	-32.88%	-37.45%	-32.12%	11.56%	-15.54%
EPS Growth	0.00%	-32.86%	-37.68%	-32.39%	11.14%	-16.54%
Operating Cash Flow Growth	0.00%	-24.37%	-5.43%	-60.28%	-6.88%	17.52%
Free Cash Flow Firm Growth	0.00%	0.00%	85.33%	321.77%	43.35%	-35.62%
Invested Capital Growth	0.00%	0.00%	40.02%	6.18%	9.32%	8.50%
Revenue Q/Q Growth	0.00%	0.00%	-0.16%	-1.88%	1.84%	-0.09%
EBITDA Q/Q Growth	0.00%	0.00%	-7.69%	-5.24%	1.75%	4.30%
EBIT Q/Q Growth	0.00%	0.00%	-9.70%	-5.34%	1.42%	3.85%
NOPAT Q/Q Growth	0.00%	0.00%	-5.25%	-2.30%	77.11%	-33.27%
Net Income Q/Q Growth	0.00%	0.00%	-10.94%	-9.30%	74.87%	-33.59%
EPS Q/Q Growth	0.00%	0.00%	-11.06%	-9.11%	74.24%	-33.80%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	-16.83%	34.48%	19.43%	-0.74%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.67%	118.71%	-42.53%
Invested Capital Q/Q Growth	0.00%	0.00%	3.25%	2.54%	4.52%	2.34%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	70.76%	67.56%	61.94%	62.84%	59.84%	58.02%
EBITDA Margin	51.81%	44.31%	31.44%	28.68%	23.17%	25.38%
Operating Margin	48.37%	42.67%	28.41%	25.43%	20.07%	21.46%
EBIT Margin	47.52%	42.13%	28.35%	25.25%	19.40%	21.05%
Profit (Net Income) Margin	41.38%	33.07%	21.43%	14.85%	16.33%	13.49%
Tax Burden Percent	87.07%	78.49%	88.36%	81.73%	152.01%	107.06%
Interest Burden Percent	100.00%	100.00%	85.56%	71.97%	55.39%	59.87%
Effective Tax Rate	10.55%	18.02%	11.64%	18.27%	-52.01%	-7.06%
Return on Invested Capital (ROIC)	0.00%	92.87%	26.80%	18.07%	24.96%	17.64%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	136.93%	20.89%	13.66%	14.05%	10.18%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-14.13%	41.12%	-94.48%	-237.64%	412.21%
Return on Equity (ROE)	0.00%	78.75%	67.92%	-76.42%	-212.68%	429.85%
Cash Return on Invested Capital (CROIC)	0.00%	-107.13%	-6.55%	12.07%	16.05%	9.49%
Operating Return on Assets (OROA)	0.00%	27.22%	17.19%	14.41%	10.56%	10.72%
Return on Assets (ROA)	0.00%	21.37%	13.00%	8.48%	8.89%	6.87%
Return on Common Equity (ROCE)	0.00%	78.75%	67.92%	-76.42%	-212.68%	429.85%
Return on Equity Simple (ROE_SIMPLE)	0.00%	39.37%	-89.59%	-102.80%	-1,461.43%	183.05%
Net Operating Profit after Tax (NOPAT)	3,365	2,285	1,582	1,283	1,911	1,471
NOPAT Margin	43.27%	34.98%	25.10%	20.78%	30.51%	22.97%
Net Nonoperating Expense Percent (NNEP)	0.00%	-44.06%	5.91%	4.41%	10.91%	7.46%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	16.00%	21.99%	15.73%
Cost of Revenue to Revenue	29.24%	32.44%	38.06%	37.16%	40.16%	41.98%
SG&A Expenses to Revenue	18.55%	20.76%	26.46%	27.60%	30.23%	27.49%
R&D to Revenue	2.83%	3.21%	7.03%	9.36%	8.56%	8.59%
Operating Expenses to Revenue	22.39%	24.89%	33.53%	37.42%	39.77%	36.56%
Earnings before Interest and Taxes (EBIT)	3,696	2,752	1,787	1,559	1,215	1,348
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	4,029	2,894	1,982	1,771	1,451	1,625
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	7.99
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	1.05	1.00	0.54	0.59
Price to Earnings (P/E)	0.00	0.00	4.91	6.74	3.33	4.37
Dividend Yield	0.00%	0.00%	2.14%	6.92%	8.40%	7.64%
Earnings Yield	0.00%	0.00%	20.37%	14.84%	30.03%	22.90%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	2.18	1.97	1.43	1.38
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	2.38	2.33	1.83	1.87
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	7.58	8.12	7.91	7.37
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	8.41	9.23	9.44	8.89
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	9.50	11.21	6.01	8.14
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	6.96	16.77	14.36	12.76
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	16.78	9.34	15.14
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.00	0.00	-6.06	-9.99	-125.14	18.81
Long-Term Debt to Equity	0.00	0.00	-6.05	-9.98	-125.01	18.77
Financial Leverage	0.00	-0.10	1.97	-6.92	-16.92	40.48
Leverage Ratio	0.00	1.84	5.23	-9.02	-23.92	62.58
Compound Leverage Factor	0.00	1.84	4.47	-6.49	-13.25	37.47
Debt to Total Capital	0.00%	0.00%	119.77%	111.12%	100.81%	94.95%
Short-Term Debt to Total Capital	0.00%	0.00%	0.12%	0.10%	0.10%	0.21%
Long-Term Debt to Total Capital	0.00%	0.00%	119.66%	111.02%	100.70%	94.74%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	100.00%	-19.77%	-11.12%	-0.81%	5.05%
Debt to EBITDA	0.00	0.00	4.61	5.03	6.04	5.46
Net Debt to EBITDA	0.00	0.00	4.24	4.63	5.56	5.05
Long-Term Debt to EBITDA	0.00	0.00	4.60	5.03	6.03	5.45
Debt to NOPAT	0.00	0.00	5.77	6.95	4.58	6.04
Net Debt to NOPAT	0.00	0.00	5.31	6.40	4.22	5.58
Long-Term Debt to NOPAT	0.00	0.00	5.77	6.94	4.58	6.02
Altman Z-Score	0.00	0.00	1.47	1.46	1.23	1.26
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	0.00	1.33	1.45	1.56	1.54	1.60
Quick Ratio	0.00	0.39	0.82	0.87	0.84	0.75
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-2,635	-387	857	1,229	791
Operating Cash Flow to CapEx	3,431.82%	913.60%	1,167.57%	453.97%	319.60%	549.12%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	-1.50	1.96	2.27	1.46
Operating Cash Flow to Interest Expense	0.00	0.00	8.37	1.96	1.47	1.74
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	7.66	1.53	1.01	1.42
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.00	0.65	0.61	0.57	0.54	0.51
Accounts Receivable Turnover	0.00	6.29	5.21	4.32	3.89	4.13
Inventory Turnover	0.00	2.32	2.62	2.39	2.17	2.04
Fixed Asset Turnover	0.00	6.64	6.44	6.20	5.69	5.45
Accounts Payable Turnover	0.00	1.33	1.61	1.83	2.06	2.18
Days Sales Outstanding (DSO)	0.00	58.00	70.06	84.45	93.80	88.41
Days Inventory Outstanding (DIO)	0.00	157.27	139.06	152.59	168.20	178.97
Days Payable Outstanding (DPO)	0.00	275.26	226.70	200.00	177.49	167.50
Cash Conversion Cycle (CCC)	0.00	-59.99	-17.58	37.04	84.51	99.89
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	0.00	4,920	6,889	7,315	7,997	8,677
Invested Capital Turnover	0.00	2.66	1.07	0.87	0.82	0.77
Increase / (Decrease) in Invested Capital	0.00	4,920	1,969	426	682	680
Enterprise Value (EV)	0.00	0.00	15,029	14,385	11,474	11,978
Market Capitalization	0.00	0.00	6,632	6,178	3,407	3,773
Book Value per Share	$0.00	$21.64	($5.95)	($3.51)	($0.27)	$1.83
Tangible Book Value per Share	$0.00	$1.50	($26.67)	($24.15)	($20.37)	($21.83)
Total Capital	0.00	5,486	7,626	8,021	8,690	9,352
Total Debt	0.00	0.00	9,134	8,913	8,760	8,880
Total Long-Term Debt	0.00	0.00	9,125	8,905	8,751	8,860
Net Debt	0.00	-12	8,397	8,207	8,067	8,205
Capital Expenditures (CapEx)	88	250	185	189	250	171
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	882	435	721	906	975
Debt-free Net Working Capital (DFNWC)	0.00	894	1,172	1,427	1,599	1,650
Net Working Capital (NWC)	0.00	894	1,163	1,419	1,590	1,630
Net Nonoperating Expense (NNE)	147	125	231	366	888	607
Net Nonoperating Obligations (NNO)	0.00	-566	8,397	8,207	8,067	8,205
Total Depreciation and Amortization (D&A)	333	142	195	212	236	277
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	13.50%	6.90%	11.68%	14.47%	15.23%
Debt-free Net Working Capital to Revenue	0.00%	13.69%	18.59%	23.11%	25.53%	25.77%
Net Working Capital to Revenue	0.00%	13.69%	18.45%	22.98%	25.39%	25.46%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$5.33	$3.61	$4.01	$3.36
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	253.54M	254.08M	255.24M	257.05M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$5.31	$3.59	$3.99	$3.33
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	254.19M	255.17M	256.27M	259.15M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	253.64M	254.38M	255.64M	257.95M
Normalized Net Operating Profit after Tax (NOPAT)	3,435	2,334	1,585	1,306	923	984
Normalized NOPAT Margin	44.17%	35.73%	25.15%	21.15%	14.74%	15.36%
Pre Tax Income Margin	47.52%	42.13%	24.25%	18.17%	10.75%	12.60%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	6.93	3.57	2.24	2.49
NOPAT to Interest Expense	0.00	0.00	6.13	2.94	3.53	2.72
EBIT Less CapEx to Interest Expense	0.00	0.00	6.21	3.14	1.78	2.18
NOPAT Less CapEx to Interest Expense	0.00	0.00	5.42	2.50	3.06	2.40
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	10.73%	31.62%	28.74%	34.38%
Augmented Payout Ratio	0.00%	0.00%	10.73%	31.62%	28.74%	34.38%

This table displays calculated financial ratios and metrics derived from Organon & Co.'s official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-3.94%	-7.36%	-1.85%	1.45%	-1.17%	7.61%	5.46%	-0.06%	4.15%	-0.38%
EBITDA Growth	-17.22%	-24.81%	-28.38%	2.30%	-38.48%	3.37%	1.89%	-2.92%	46.18%	16.94%
EBIT Growth	-20.08%	-26.43%	-31.91%	0.52%	-45.13%	0.82%	0.00%	-5.43%	55.61%	14.17%
NOPAT Growth	-21.42%	-4.31%	-31.69%	22.52%	-47.50%	415.24%	11.30%	-16.94%	249.54%	-81.75%
Net Income Growth	-29.72%	-46.53%	-49.14%	3.42%	-74.45%	405.56%	13.56%	-19.42%	518.97%	-80.04%
EPS Growth	-29.92%	-46.15%	-49.26%	3.26%	-74.16%	404.76%	13.04%	-21.05%	500.00%	-80.19%
Operating Cash Flow Growth	-13.86%	468.09%	-7.32%	-82.12%	-17.67%	48.69%	-33.33%	1,129.63%	-45.98%	-1.76%
Free Cash Flow Firm Growth	97.74%	90.16%	96.50%	-19.09%	-146.29%	489.68%	-355.17%	122.76%	31.17%	-167.02%
Invested Capital Growth	6.92%	6.18%	5.10%	8.85%	7.25%	9.32%	8.94%	3.15%	10.82%	8.50%
Revenue Q/Q Growth	-3.03%	-3.38%	3.57%	4.55%	-5.53%	5.20%	1.50%	-0.92%	-1.56%	0.63%
EBITDA Q/Q Growth	2.76%	-33.56%	50.35%	4.95%	-38.20%	11.64%	47.95%	0.00%	-6.94%	-10.70%
EBIT Q/Q Growth	1.30%	-37.18%	59.57%	5.45%	-44.70%	15.42%	58.19%	-0.27%	-9.02%	-15.32%
NOPAT Q/Q Growth	5.91%	-19.22%	17.81%	28.81%	-54.62%	692.81%	-74.48%	-3.87%	90.98%	-58.61%
Net Income Q/Q Growth	-2.99%	-52.42%	63.89%	36.72%	-76.03%	841.38%	-63.19%	-2.99%	84.10%	-69.64%
EPS Q/Q Growth	-3.26%	-52.81%	64.29%	37.68%	-75.79%	821.74%	-63.21%	-3.85%	84.00%	-69.57%
Operating Cash Flow Q/Q Growth	109.93%	-15.77%	-57.30%	-76.32%	866.67%	52.11%	-80.86%	336.84%	-57.53%	176.60%
Free Cash Flow Firm Q/Q Growth	36.92%	-18.05%	57.49%	-245.98%	-30.45%	286.78%	-161.42%	117.30%	-494.52%	-81.88%
Invested Capital Q/Q Growth	-1.07%	2.54%	2.73%	4.44%	-2.52%	4.52%	2.38%	-1.11%	4.73%	2.34%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	64.15%	60.27%	62.29%	60.20%	59.71%	57.26%	59.00%	58.43%	58.34%	56.28%
EBITDA Margin	29.08%	20.00%	27.57%	27.67%	18.10%	19.21%	26.63%	26.88%	25.41%	22.55%
Operating Margin	25.89%	17.91%	24.84%	24.19%	15.27%	15.89%	23.18%	23.09%	21.43%	18.09%
EBIT Margin	25.37%	16.50%	23.86%	24.07%	14.09%	15.46%	22.63%	22.78%	21.05%	17.71%
Profit (Net Income) Margin	14.77%	7.27%	11.51%	15.05%	3.82%	34.17%	12.39%	12.13%	22.69%	6.85%
Tax Burden Percent	80.50%	97.30%	75.32%	95.28%	72.50%	525.00%	85.17%	82.98%	173.43%	84.50%
Interest Burden Percent	72.31%	45.31%	64.03%	65.63%	37.38%	42.11%	64.31%	64.21%	62.16%	45.74%
Effective Tax Rate	19.50%	2.70%	24.68%	4.72%	27.50%	-425.00%	14.83%	17.02%	-73.43%	15.50%
Return on Invested Capital (ROIC)	19.00%	15.15%	15.68%	18.88%	9.21%	68.26%	15.96%	15.25%	29.53%	11.74%
ROIC Less NNEP Spread (ROIC-NNEP)	17.87%	13.33%	14.35%	17.34%	7.87%	58.59%	14.51%	13.87%	26.71%	10.09%
Return on Net Nonoperating Assets (RNNOA)	-109.77%	-92.25%	-120.24%	-171.72%	-78.19%	-991.10%	-345.10%	-551.91%	-4,514.71%	408.36%
Return on Equity (ROE)	-90.77%	-77.10%	-104.56%	-152.84%	-68.98%	-922.84%	-329.14%	-536.66%	-4,485.18%	420.10%
Cash Return on Invested Capital (CROIC)	12.33%	12.07%	10.61%	7.65%	7.60%	16.05%	15.90%	20.23%	17.07%	9.49%
Operating Return on Assets (OROA)	14.67%	9.42%	13.73%	13.75%	8.08%	8.41%	12.68%	12.50%	11.35%	9.02%
Return on Assets (ROA)	8.54%	4.15%	6.62%	8.60%	2.19%	18.60%	6.94%	6.66%	12.24%	3.49%
Return on Common Equity (ROCE)	-90.77%	-77.10%	-104.56%	-152.84%	-68.98%	-922.84%	-329.14%	-536.66%	-4,485.18%	420.10%
Return on Equity Simple (ROE_SIMPLE)	-94.84%	0.00%	-101.22%	-135.86%	-99.32%	0.00%	2,181.25%	694.44%	263.89%	0.00%
Net Operating Profit after Tax (NOPAT)	320	259	288	371	168	1,334	320	308	588	243
NOPAT Margin	20.84%	17.43%	18.71%	23.05%	11.07%	83.45%	19.74%	19.16%	37.16%	15.29%
Net Nonoperating Expense Percent (NNEP)	1.13%	1.82%	1.33%	1.54%	1.34%	9.68%	1.45%	1.38%	2.82%	1.65%
Return On Investment Capital (ROIC_SIMPLE)	-	3.23%	-	-	-	15.35%	-	-	-	2.60%
Cost of Revenue to Revenue	35.85%	39.73%	37.71%	39.80%	40.29%	42.74%	41.00%	41.57%	41.66%	43.72%
SG&A Expenses to Revenue	28.63%	31.65%	28.28%	28.05%	35.42%	29.35%	26.57%	27.19%	26.68%	29.52%
R&D to Revenue	8.91%	9.56%	8.91%	7.96%	9.02%	8.39%	7.83%	8.15%	10.24%	8.17%
Operating Expenses to Revenue	38.26%	42.36%	37.45%	36.01%	44.44%	41.36%	35.82%	35.35%	36.92%	38.19%
Earnings before Interest and Taxes (EBIT)	390	245	367	387	214	247	367	366	333	282
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	447	297	424	445	275	307	432	432	402	359
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	97.38	36.46	9.99	7.99
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.83	1.00	0.89	0.79	0.67	0.54	0.74	0.83	0.77	0.59
Price to Earnings (P/E)	5.18	6.74	7.31	6.50	7.09	3.33	4.46	5.25	3.79	4.37
Dividend Yield	6.79%	6.92%	6.54%	7.29%	8.63%	8.40%	6.12%	5.49%	5.85%	7.64%
Earnings Yield	19.29%	14.84%	13.69%	15.39%	14.11%	30.03%	22.40%	19.05%	26.41%	22.90%
Enterprise Value to Invested Capital (EV/IC)	1.88	1.97	1.82	1.69	1.62	1.43	1.57	1.63	1.52	1.38
Enterprise Value to Revenue (EV/Rev)	2.14	2.33	2.23	2.16	2.01	1.83	2.02	2.08	2.01	1.87
Enterprise Value to EBITDA (EV/EBITDA)	7.19	8.12	8.63	8.33	8.69	7.91	8.87	9.23	8.29	7.37
Enterprise Value to EBIT (EV/EBIT)	8.16	9.23	9.99	9.68	10.34	9.44	10.68	11.20	9.95	8.89
Enterprise Value to NOPAT (EV/NOPAT)	10.23	11.21	11.99	10.96	11.48	6.01	6.67	7.10	5.86	8.14
Enterprise Value to Operating Cash Flow (EV/OCF)	21.07	16.77	16.14	18.35	18.51	14.36	16.84	12.38	13.65	12.76
Enterprise Value to Free Cash Flow (EV/FCFF)	15.79	16.78	17.61	23.10	22.05	9.34	10.27	8.19	9.38	15.14
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-8.16	-9.99	-11.82	-15.73	-14.69	-125.14	181.54	60.11	17.75	18.81
Long-Term Debt to Equity	-8.15	-9.98	-11.81	-15.72	-14.68	-125.01	181.35	60.05	17.73	18.77
Financial Leverage	-6.14	-6.92	-8.38	-9.90	-9.93	-16.92	-23.79	-39.80	-169.02	40.48
Leverage Ratio	-8.11	-9.02	-10.75	-12.76	-12.96	-23.92	-32.88	-56.28	-247.54	62.58
Compound Leverage Factor	-5.87	-4.08	-6.88	-8.38	-4.84	-10.07	-21.14	-36.14	-153.88	28.63
Debt to Total Capital	113.97%	111.12%	109.24%	106.79%	107.30%	100.81%	99.45%	98.36%	94.67%	94.95%
Short-Term Debt to Total Capital	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.10%	0.11%	0.21%
Long-Term Debt to Total Capital	113.86%	111.02%	109.14%	106.69%	107.20%	100.70%	99.35%	98.26%	94.56%	94.74%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-13.97%	-11.12%	-9.24%	-6.79%	-7.30%	-0.81%	0.55%	1.64%	5.33%	5.05%
Debt to EBITDA	4.65	5.03	5.49	5.46	6.07	6.04	6.03	6.05	5.62	5.46
Net Debt to EBITDA	4.39	4.63	5.20	5.26	5.78	5.56	5.64	5.56	5.13	5.05
Long-Term Debt to EBITDA	4.65	5.03	5.48	5.46	6.06	6.03	6.03	6.04	5.61	5.45
Debt to NOPAT	6.62	6.95	7.62	7.19	8.02	4.58	4.54	4.65	3.97	6.04
Net Debt to NOPAT	6.24	6.40	7.22	6.92	7.64	4.22	4.24	4.28	3.62	5.58
Long-Term Debt to NOPAT	6.62	6.94	7.61	7.19	8.01	4.58	4.53	4.65	3.96	6.02
Altman Z-Score	1.09	1.06	1.10	1.10	1.00	0.97	1.11	1.14	1.12	1.00
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.54	1.56	1.61	1.66	1.63	1.54	1.65	1.64	1.70	1.60
Quick Ratio	0.83	0.87	0.81	0.84	0.83	0.84	0.83	0.84	0.88	0.75
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-142	-167	-77	-267	-349	652	-352	61	-240	-437
Operating Cash Flow to CapEx	598.11%	452.54%	247.83%	38.03%	474.55%	502.53%	165.22%	1,037.50%	343.90%	735.85%
Free Cash Flow to Firm to Interest Expense	-1.31	-1.25	-0.59	-2.01	-2.60	4.56	-2.69	0.46	-1.91	-2.85
Operating Cash Flow to Interest Expense	2.94	1.99	0.86	0.20	1.95	2.78	0.58	2.53	1.12	2.55
Operating Cash Flow Less CapEx to Interest Expense	2.44	1.55	0.52	-0.33	1.54	2.22	0.23	2.29	0.79	2.20
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.58	0.57	0.58	0.57	0.57	0.54	0.56	0.55	0.54	0.51
Accounts Receivable Turnover	4.28	4.32	4.44	3.90	3.98	3.89	4.24	3.86	3.85	4.13
Inventory Turnover	2.58	2.39	2.25	2.21	2.36	2.17	2.19	2.13	2.09	2.04
Fixed Asset Turnover	6.72	6.20	6.07	5.98	6.14	5.69	5.68	5.59	5.57	5.45
Accounts Payable Turnover	1.72	1.83	2.24	2.12	2.33	2.06	2.68	2.24	2.49	2.18
Days Sales Outstanding (DSO)	85.22	84.45	82.18	93.56	91.64	93.80	86.03	94.59	94.91	88.41
Days Inventory Outstanding (DIO)	141.36	152.59	162.32	165.06	154.64	168.20	166.38	171.66	174.29	178.97
Days Payable Outstanding (DPO)	212.47	200.00	163.10	172.44	156.89	177.49	136.16	162.82	146.47	167.50
Cash Conversion Cycle (CCC)	14.10	37.04	81.39	86.18	89.39	84.51	116.25	103.42	122.73	99.89
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	7,134	7,315	7,515	7,849	7,651	7,997	8,187	8,096	8,479	8,677
Invested Capital Turnover	0.91	0.87	0.84	0.82	0.83	0.82	0.81	0.80	0.79	0.77
Increase / (Decrease) in Invested Capital	462	426	365	638	517	682	672	247	828	680
Enterprise Value (EV)	13,441	14,385	13,702	13,304	12,386	11,474	12,813	13,202	12,911	11,978
Market Capitalization	5,241	6,178	5,450	4,900	4,146	3,407	4,674	5,250	4,925	3,773
Book Value per Share	($4.19)	($3.51)	($2.90)	($2.18)	($2.30)	($0.27)	$0.19	$0.56	$1.91	$1.83
Tangible Book Value per Share	($24.92)	($24.15)	($23.43)	($22.54)	($22.51)	($20.37)	($20.62)	($20.00)	($18.93)	($21.83)
Total Capital	7,633	8,021	7,974	8,175	8,065	8,690	8,762	8,800	9,242	9,352
Total Debt	8,699	8,913	8,711	8,730	8,654	8,760	8,714	8,656	8,749	8,880
Total Long-Term Debt	8,691	8,905	8,703	8,722	8,646	8,751	8,705	8,647	8,739	8,860
Net Debt	8,200	8,207	8,252	8,404	8,240	8,067	8,139	7,952	7,986	8,205
Capital Expenditures (CapEx)	53	59	46	71	55	79	46	32	41	53
Debt-free, Cash-free Net Working Capital (DFCFNWC)	773	721	983	1,253	1,153	906	1,085	1,059	1,213	975
Debt-free Net Working Capital (DFNWC)	1,272	1,427	1,442	1,579	1,567	1,599	1,660	1,763	1,976	1,650
Net Working Capital (NWC)	1,264	1,419	1,434	1,571	1,559	1,590	1,651	1,754	1,966	1,630
Net Nonoperating Expense (NNE)	93	151	111	129	110	788	119	113	229	134
Net Nonoperating Obligations (NNO)	8,200	8,207	8,252	8,404	8,240	8,067	8,139	7,952	7,986	8,205
Total Depreciation and Amortization (D&A)	57	52	57	58	61	60	65	66	69	77
Debt-free, Cash-free Net Working Capital to Revenue	12.29%	11.68%	16.00%	20.31%	18.75%	14.47%	17.09%	16.69%	18.93%	15.23%
Debt-free Net Working Capital to Revenue	20.22%	23.11%	23.47%	25.60%	25.48%	25.53%	26.15%	27.78%	30.83%	25.77%
Net Working Capital to Revenue	20.09%	22.98%	23.34%	25.47%	25.35%	25.39%	26.01%	27.64%	30.68%	25.46%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.89	$0.43	$0.70	$0.95	$0.23	$2.13	$0.78	$0.76	$1.39	$0.43
Adjusted Weighted Average Basic Shares Outstanding	254.35M	254.08M	254.39M	255.34M	255.59M	255.24M	255.70M	257.29M	257.50M	257.05M
Adjusted Diluted Earnings per Share	$0.89	$0.42	$0.69	$0.95	$0.23	$2.12	$0.78	$0.75	$1.38	$0.42
Adjusted Weighted Average Diluted Shares Outstanding	255.07M	255.17M	256.17M	255.95M	256.35M	256.27M	258.36M	258.60M	259.76M	259.15M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	254.36M	254.38M	255.06M	255.57M	255.61M	255.64M	257.17M	257.47M	257.54M	257.95M
Normalized Net Operating Profit after Tax (NOPAT)	329	275	291	371	168	218	340	308	237	250
Normalized NOPAT Margin	21.42%	18.54%	18.90%	23.05%	11.07%	13.67%	20.95%	19.16%	15.00%	15.71%
Pre Tax Income Margin	18.35%	7.47%	15.28%	15.80%	5.27%	6.51%	14.55%	14.62%	13.08%	8.10%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	3.61	1.83	2.78	2.91	1.60	1.73	2.80	2.79	2.64	1.84
NOPAT to Interest Expense	2.97	1.93	2.18	2.79	1.26	9.33	2.44	2.35	4.67	1.59
EBIT Less CapEx to Interest Expense	3.12	1.39	2.43	2.38	1.19	1.17	2.45	2.55	2.32	1.50
NOPAT Less CapEx to Interest Expense	2.48	1.49	1.83	2.25	0.84	8.77	2.09	2.11	4.34	1.24
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	28.49%	31.62%	39.14%	38.99%	50.26%	28.74%	27.79%	29.60%	22.75%	34.38%
Augmented Payout Ratio	28.49%	31.62%	39.14%	38.99%	50.26%	28.74%	27.79%	29.60%	22.75%	34.38%

Frequently Asked Questions About Organon & Co.'s Financials

When does Organon & Co.'s financial year end?

According to the most recent income statement we have on file, Organon & Co.'s fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Organon & Co.'s net income changed over the last 5 years?

Organon & Co.'s net income appears to be on a downward trend, with a most recent value of $864 million in 2024, falling from $3.22 billion in 2019. The previous period was $1.02 billion in 2023.

What is Organon & Co.'s operating income?

Organon & Co.'s total operating income in 2024 was $1.37 billion, based on the following breakdown:

Total Gross Profit: $3.72 billion
Total Operating Expenses: $2.34 billion

How has Organon & Co. revenue changed over the last 5 years?

Over the last 5 years, Organon & Co.'s total revenue changed from $7.78 billion in 2019 to $6.40 billion in 2024, a change of -17.7%.

How much debt does Organon & Co. have?

Organon & Co.'s total liabilities were at $12.63 billion at the end of 2024, a 4.1% increase from 2023, and a 173.2% increase since 2020.

How much cash does Organon & Co. have?

In the past 4 years, Organon & Co.'s cash and equivalents has ranged from $12 million in 2020 to $737 million in 2021, and is currently $675 million as of their latest financial filing in 2024.

How has Organon & Co.'s book value per share changed over the last 5 years?

Over the last 5 years, Organon & Co.'s book value per share changed from 0.00 in 2019 to 1.83 in 2024, a change of 183.3%.

Remove Ads

Related Companies

This page (NYSE:OGN) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Organon & Co. (OGN) Financials

Frequently Asked Questions About Organon & Co.'s Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Organon & Co. (OGN) Financials

Annual Income Statements for Organon & Co.

Quarterly Income Statements for Organon & Co.

Annual Cash Flow Statements for Organon & Co.

Quarterly Cash Flow Statements for Organon & Co.

Annual Balance Sheets for Organon & Co.

Quarterly Balance Sheets for Organon & Co.

Annual Metrics and Ratios for Organon & Co.

Quarterly Metrics and Ratios for Organon & Co.

Frequently Asked Questions About Organon & Co.'s Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools